Literature DB >> 10965629

Recommendations for a cost-offset model of psychotherapy allocation using generalized anxiety disorder as an example.

M G Newman1.   

Abstract

As inexpensive interventions gain empirical support, there is an increasing risk that such data may be used by health maintenance organizations to unfairly restrict the number and type of therapy sessions reimbursed for all clients, even those less likely to benefit from economical treatments. As a result, it is important to identify clients who may not respond to specific therapies and to empirically support ways to treat them. Successful treatment of nonresponders is also valuable because predictors of treatment failure tend to predict cost related to medical and disability expenses. Using generalized anxiety disorder as an example, this article suggests a flexible and comprehensive approach to cost-benefit analysis in psychotherapy that includes clients who may not improve in response to current data-based interventions. In addition, suggestions are made for the identification of alternative treatment approaches, and a potential treatment allocation model is recommended.

Entities:  

Mesh:

Year:  2000        PMID: 10965629

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  36 in total

1.  Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.

Authors:  Michelle G Newman; Amy Przeworski; Aaron J Fisher; Thomas D Borkovec
Journal:  Behav Ther       Date:  2009-06-08

2.  Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Kenneth B Stoller; Karin J Neufeld; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2007-01-24       Impact factor: 4.492

Review 3.  Finding the ideal place for a psychotherapeutic intervention in a stepped care approach--a brief overview of the literature and preliminary results from the Project PREDICT.

Authors:  M Berner; C Günzler; K Frick; L Kriston; B Loessl; R Brück; H Gann; A Batra; K Mann
Journal:  Int J Methods Psychiatr Res       Date:  2008-06       Impact factor: 4.035

4.  AN OPEN TRIAL OF INTEGRATIVE THERAPY FOR GENERALIZED ANXIETY DISORDER.

Authors:  Michelle G Newman; Louis G Castonguay; Thomas D Borkovec; Aaron J Fisher; Samuel S Nordberg
Journal:  Psychotherapy (Chic)       Date:  2008-06-01

5.  Effect of a stepped-care intervention approach on weight loss in adults: a randomized clinical trial.

Authors:  John M Jakicic; Deborah F Tate; Wei Lang; Kelli K Davis; Kristen Polzien; Amy D Rickman; Karen Erickson; Rebecca H Neiberg; Eric A Finkelstein
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

6.  A randomized controlled trial of ecological momentary intervention plus brief group therapy for generalized anxiety disorder.

Authors:  Michelle G Newman; Amy Przeworski; Andrés J Consoli; C Barr Taylor
Journal:  Psychotherapy (Chic)       Date:  2013-09-23

7.  Long-Term Effects of Two Formats of Cognitive Behavioral Therapy for Insomnia Comorbid with Breast Cancer.

Authors:  Josée Savard; Hans Ivers; Marie-Hélène Savard; Charles M Morin
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

Review 8.  Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment.

Authors:  Michelle G Newman; Sandra J Llera; Thane M Erickson; Amy Przeworski; Louis G Castonguay
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

9.  Internet-delivered, family-based treatment for early-onset OCD: a preliminary case series.

Authors:  Jonathan S Comer; Jami M Furr; Christine E Cooper-Vince; Caroline E Kerns; Priscilla T Chan; Aubrey L Edson; Muniya Khanna; Martin E Franklin; Abbe M Garcia; Jennifer B Freeman
Journal:  J Clin Child Adolesc Psychol       Date:  2013-12-02

10.  Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial.

Authors:  Josée Savard; Hans Ivers; Marie-Hélène Savard; Charles M Morin
Journal:  Sleep       Date:  2014-08-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.